Target intelligence / Profile preview

Scm-like with four MBT domains protein 1 (SFMBT1)

Target
SFMBT1
Molecular classification
Histone modification protein, Chromatin-associated protein, Transcription corepressor
01

Overview

Scm-like with four MBT domains protein 1 (SFMBT1) is a chromatin-associated protein containing four malignant brain tumor (MBT) domains, homologous to members of the Polycomb group found in *Drosophila*[1][2][3]. SFMBT1 primarily acts as a transcriptional corepressor, modulating the expression of target genes through chromatin compaction and repression. It performs these functions as part of stable complexes with LSD1 and CoREST, both in somatic cells and during spermatogenesis. SFMBT1’s MBT domains bind histone tails and are essential for chromatin-binding, transcriptional repression, and the recruitment of histone-modifying complexes. It regulates genes involved in chromatin and nucleosome assembly, notably replication-dependent histone gene clusters, with roles in cell cycle progression and maintenance of undifferentiated myogenic progenitor cells through interaction with MYOD1. SFMBT1 is associated with bone sarcoma and other cancers. Currently, no drugs, biomarkers, or specific safety concerns are documented for SFMBT1 in clinical literature[1][2][3][4].

Other names
Scm-like with four MBT domains 1SFMBThSFMBTRU1DKFZp434L243Smr4930442N21Rik9330180L21RIKLOC680626LOC102723651Renal ubiquitous protein 1Scm-related gene containing four MBT domainsScm-related gene product containing four MBT domains
02

Biological functions

Chromatin compactionTranscriptional repressionGene regulation (esp. replication-dependent histone genes)Maintenance of undifferentiated myogenic progenitor cellsParticipation in spermatogenesis
03

Disease associations

Cancer (bone sarcoma, sarcoma)Potential roles in other epigenetic disorders

Beyond the preview

Go deeper on Scm-like with four MBT domains protein 1 (SFMBT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scm-like with four MBT domains protein 1 (SFMBT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call